Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
JMIR Medical Informatics|June 21, 2024
Natural Language Processing-Powered Real-Time Monitoring Solution for Vaccine Sentiments and Hesitancy on Social Media: System Development and ValidationLiang-Chin Huang, Amanda L Eiden, Long He, et al.
Journal of Telemedicine and Telecare|November 25, 2010
Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility studyNeal J Meropol, Mary B Daly, Hetal S Vig, et al.
BMC Bioinformatics|June 18, 2009
FuGEFlow: data model and markup language for flow cytometryYu Qian, Olga Tchuvatkina, Josef Spidlen, et al.
Journal of the American Medical Informatics Association : JAMIA|November 12, 2023
AutoCriteria: a generalizable clinical trial eligibility criteria extraction system powered by large language modelsSurabhi Datta, Kyeryoung Lee, Hunki Paek, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2021
COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data modelJingqi Wang, Noor Abu-El-Rub, Josh Gray, et al.
Arxiv|September 10, 2020
COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data modelJingqi Wang, Noor Abu-El-Rub, Josh Gray, et al.
JMIR Medical Informatics|October 23, 2024
Accelerating Evidence Synthesis in Observational Studies: Development of a Living Natural Language Processing-Assisted Intelligent Systematic Literature Review SystemFrank J Manion, Jingcheng Du, Dong Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|January 3, 2001
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trialD W Haas, W J Fessel, R A Delapenha, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
Pageof 7